Novo Nordisk A/S ADR (NY: NVO )

105.06 +2.43 (+2.37%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist

Other Filings

Form 6-K
Source: SEC/Edgar
May 02, 2019
Form 6-K
Source: SEC/Edgar
May 02, 2019
Form 6-K
Source: SEC/Edgar
May 01, 2019
Form 6-K
Source: SEC/Edgar
April 30, 2019
Form 6-K
Source: SEC/Edgar
April 29, 2019
Form 6-K
Source: SEC/Edgar
April 28, 2019
Form 6-K
Source: SEC/Edgar
April 24, 2019
Form 6-K
Source: SEC/Edgar
April 16, 2019
Form 6-K
Source: SEC/Edgar
April 07, 2019
Form 6-K
Source: SEC/Edgar
March 31, 2019
Form 6-K
Source: SEC/Edgar
March 25, 2019
Form 6-K
Source: SEC/Edgar
March 24, 2019
Form 6-K
Source: SEC/Edgar
March 20, 2019
Form 6-K
Source: SEC/Edgar
March 19, 2019
Form 6-K
Source: SEC/Edgar
March 18, 2019
Form 6-K
Source: SEC/Edgar
March 17, 2019
Form 6-K
Source: SEC/Edgar
March 10, 2019
Form 6-K
Source: SEC/Edgar
March 05, 2019
Form 6-K
Source: SEC/Edgar
February 24, 2019
Form 6-K
Source: SEC/Edgar
February 21, 2019
Form 6-K
Source: SEC/Edgar
February 19, 2019
Form 6-K
Source: SEC/Edgar
February 18, 2019
Form 6-K
Source: SEC/Edgar
February 13, 2019
Form 6-K
Source: SEC/Edgar
February 11, 2019
Form SC 13G/A
Source: SEC/Edgar
February 05, 2019
Form 6-K
Source: SEC/Edgar
February 04, 2019
Form 6-K
Source: SEC/Edgar
February 03, 2019
Form 20-F
Source: SEC/Edgar
February 03, 2019
Form IRANNOTICE
Source: SEC/Edgar
February 03, 2019
Form 6-K
Source: SEC/Edgar
January 31, 2019
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.